Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03620578
Title DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL (HO152)
Acronym HO152
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stichting Hemato-Oncologie voor Volwassenen Nederland
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | BEL

Facility Status City State Zip Country Details
BE-Antwerpen-ZNASTUIVENBERG Antwerpen Belgium Details
BE-Leuven-UZLEUVEN Leuven Belgium Details
NL-Almere-FLEVOZIEKENHUIS Almere Netherlands Details
NL-Amersfoort-MEANDERMC Amersfoort Netherlands Details
NL-Amsterdam-AMC Amsterdam Netherlands Details
NL-Amsterdam-VUMC Amsterdam Netherlands Details
NL-Den Bosch-JBZ Den Bosch Netherlands Details
NL-Den Haag-HAGA Den Haag Netherlands Details
NL-Eindhoven-MAXIMAMC Eindhoven Netherlands Details
NL-Enschede-MST Enschede Netherlands Details
NL-Goes-ADRZ Goes Netherlands Details
NL-Groningen-UMCG Groningen Netherlands Details
NL-Hoofddorp-SPAARNEGASTHUIS Hoofddorp Netherlands Details
NL-Hoorn-DIJKLANDERHOORN Hoorn Netherlands Details
NL-Leeuwarden-MCL Leeuwarden Netherlands Details
NL-Leiden-LUMC Leiden Netherlands Details
NL-Maastricht-MUMC Maastricht Netherlands Details
NL-Nijmegen-RADBOUDUMC Nijmegen Netherlands Details
NL-Rotterdam-ERASMUSMC Rotterdam Netherlands Details
NL-Rotterdam-MAASSTADZIEKENHUIS Rotterdam Netherlands Details
NL-Sittard-Geleen-ZUYDERLAND Sittard Netherlands Details
NL-Tilburg-ETZ Tilburg Netherlands Details
NL-Utrecht-UMCUTRECHT Utrecht Netherlands Details
NL-Zwolle-ISALA Zwolle Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field